Nisa Investment Advisors’s Chinook Therapeutics, Inc. Common Stock KDNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-1,674
| Closed | -$64.3K | – | 2883 |
|
|
2023
Q2 | $64.3K | Buy |
1,674
+730
| +77% | +$18.7K | ﹤0.01% | 1660 |
|
|
2023
Q1 | $22K | Hold |
944
| – | – | ﹤0.01% | 1988 |
|
|
2022
Q4 | $25K | Hold |
944
| – | – | ﹤0.01% | 2002 |
|
|
2022
Q3 | $20K | Buy |
944
+42
| +5% | +$842 | ﹤0.01% | 2061 |
|
|
2022
Q2 | $16K | Buy |
902
+570
| +172% | +$8.95K | ﹤0.01% | 2105 |
|
|
2022
Q1 | $5K | Sell |
332
-140
| -30% | -$1.9K | ﹤0.01% | 2318 |
|
|
2021
Q4 | $6K | Hold |
472
| – | – | ﹤0.01% | 2087 |
|
|
2021
Q3 | $6 | Hold |
472
| – | – | ﹤0.01% | 2250 |
|
|
2021
Q2 | $7 | Hold |
472
| – | – | ﹤0.01% | 2265 |
|
|
2021
Q1 | $7 | Hold |
472
| – | – | ﹤0.01% | 2244 |
|
|
2020
Q4 | $7K | Buy |
472
+200
| +74% | +$3.02K | ﹤0.01% | 2256 |
|
|
2020
Q3 | $3K | Hold |
272
| – | – | ﹤0.01% | 2229 |
|
|
2020
Q2 | $3K | Hold |
272
| – | – | ﹤0.01% | 2043 |
|
|
2020
Q1 | $4K | Buy |
+272
| New | +$3.22K | ﹤0.01% | 1987 |
|
|
2019
Q3 | – | Sell |
-300
| Closed | -$2K | – | 2060 |
|
|
2019
Q2 | $2K | Hold |
300
| – | – | ﹤0.01% | 1989 |
|
|
2019
Q1 | $6K | Hold |
300
| – | – | ﹤0.01% | 1887 |
|
|
2018
Q4 | $4K | Buy |
300
+196
| +188% | +$3.92K | ﹤0.01% | 1859 |
|
|
2018
Q3 | $4K | Sell |
104
-40
| -28% | -$1.28K | ﹤0.01% | 1910 |
|
|
2018
Q2 | $5K | Hold |
144
| – | – | ﹤0.01% | 1838 |
|
|
2018
Q1 | $7K | Sell |
144
-4,740
| -97% | -$173K | ﹤0.01% | 1749 |
|
|
2017
Q4 | $183K | Buy |
4,884
+4,680
| +2,294% | +$204K | ﹤0.01% | 1288 |
|
|
2017
Q3 | $11K | Hold |
204
| – | – | ﹤0.01% | 1732 |
|
|
2017
Q2 | $12K | Buy |
204
+140
| +219% | +$7.03K | ﹤0.01% | 1671 |
|
|
2017
Q1 | $3K | Sell |
64
-56
| -47% | -$3.16K | ﹤0.01% | 1841 |
|
|
2016
Q4 | $7K | Sell |
120
-320
| -73% | -$19.4K | ﹤0.01% | 1837 |
|
|
2016
Q3 | $27K | Hold |
440
| – | – | ﹤0.01% | 1550 |
|
|
2016
Q2 | $25K | Buy |
+440
| New | +$26.7K | ﹤0.01% | 1544 |
|
Nisa Investment Advisors's KDNY Position: Q3 2023 in Review
Nisa Investment Advisors sold out of Chinook Therapeutics, Inc. Common Stock (KDNY) in Q3 2023, closing a stake of 1,674 shares — an estimated $64.3K sold.
Nisa Investment Advisors first reported a position in KDNY in Q2 2016 and held it in 27 quarters. The position peaked at $183K in Q4 2017. 2 funds tracked by Wall St. Rank hold KDNY as of Q3 2023.
- Nisa Investment Advisors reported no remaining Chinook Therapeutics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
- Nisa Investment Advisors sold 1,674 Chinook Therapeutics, Inc. Common Stock shares in Q3 2023, an estimated $64.3K.
- Nisa Investment Advisors first reported a position in Chinook Therapeutics, Inc. Common Stock in Q2 2016 and held it in 27 quarters.
- Nisa Investment Advisors's Chinook Therapeutics, Inc. Common Stock position peaked at $183K in Q4 2017.
- 2 funds tracked by Wall St. Rank held Chinook Therapeutics, Inc. Common Stock as of Q3 2023.
Based on Nisa Investment Advisors's 13F filing for Q3 2023, filed 2 Nov 2023.